Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia

Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)

(2014) Cecilie J. Sørensen et al.   PLoS One

The Neuroimmunology of Schizophrenia

(2014) Annya M et al.   Clinical Psychopharmacology and Neuroscience

Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain

(2013) S. Lyngbaek et al.   CLINICAL CHEMISTRY

The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status

(2013) A. Heraclides et al.   DIABETOLOGIA

Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

(2013) Sinead M. Gibney et al.   Journal of Neuroimmune Pharmacology

Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention

(2012) Stig Lyngbæk et al.   AMERICAN JOURNAL OF CARDIOLOGY

Autoimmune diseases and infections as risk factors for schizophrenia

(2012) Michael E. Benros et al.   Annals of the New York Academy of Sciences

Life expectancy and cardiovascular mortality in persons with schizophrenia

(2012) Thomas M. Laursen et al.   CURRENT OPINION IN PSYCHIATRY

Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far?

(2012) Rasmus Røge et al.   SCHIZOPHRENIA RESEARCH

Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study

(2011) M. Persson et al.   ATHEROSCLEROSIS

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

The safety of atypical antipsychotics: does QTc provide all the answers?

(2011) Jimmi Nielsen   Expert Opinion On Drug Safety

Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study

(2011) R. Huttunen et al.   JOURNAL OF INTERNAL MEDICINE

suPAR - a future risk marker

(2011) Jesper Eugen-Olsen   JOURNAL OF INTERNAL MEDICINE

Genome-wide association study identifies five new schizophrenia loci

(2011)   NATURE GENETICS

Characteristics and predictors of long-term institutionalization in patients with schizophrenia

(2011) Peter Uggerby et al.   SCHIZOPHRENIA RESEARCH

Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement

(2010) G. Candore et al.   CURRENT PHARMACEUTICAL DESIGN

Determinants of Poor Dental Care in Patients With Schizophrenia

(2010) Jimmi Nielsen et al.   JOURNAL OF CLINICAL PSYCHIATRY

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders

(2010) Wijnand Laan et al.   JOURNAL OF CLINICAL PSYCHIATRY

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

(2009) Benjamin I. Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

(2008) J. McGrath et al.   EPIDEMIOLOGIC REVIEWS

Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor

(2008) K. Kofoed et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES